SARS CoV 2 News and Research

RSS

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Pregnant people who are hospitalized with COVID-19 in Sub-Saharan Africa are dying at a rate far greater than pregnant people without COVID-19 and non-pregnant people with COVID-19, according to a new multicenter study encompassing six African countries.

8 Jun 2022

Study demonstrates mental health changes in the adult European population during the COVID-19 pandemic

Scientists from Denmark have recently evaluated the impact of the COVID-19 pandemic on mental health in older adults.

8 Jun 2022

The association between vitamin D status and infections, hospitalization, and mortality due to COVID-19

Researchers explored the associations between vitamin D levels and SARS-CoV-2 infections, hospitalizations, and deaths in England.

8 Jun 2022

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

In a recent study, researchers analyzed the incidence of myocarditis among COVID-19 mRNA-1273 vaccinees.

8 Jun 2022

The origin of monkeypox outbreaks in non-endemic nations

In a recent review, the author explained the causes of the mysterious origin of the recent monkeypox outbreaks in non-endemic nations outside Africa.

8 Jun 2022

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Researchers assessed the proportion of receptor-binding domain antibodies in COVID-19-recovered patients.

8 Jun 2022

Pregnant women's social contacts and COVID vaccination coverage in 19 European countries

In a recent study posted to the medRxiv* pre-print server, researchers from the London School of Hygiene and Tropical Medicine and Hasselt University surveyed the social contact patterns and coronavirus disease 2019 (COVID-19) vaccine uptake among women from 19 European countries pregnant between March 2020 and September 2021.

8 Jun 2022

Newly identified coronavirus seems to be well established in Sweden's red-backed voles

Researchers from the Zoonosis Science Center at Uppsala University have identified a new coronavirus. Their study of approximately 260 bank voles caught around Grimsö, örebro County, shows that the virus is well established in Sweden's red-backed voles. The finding has been published in the journal Viruses.

8 Jun 2022

Where did Omicron's unique spike gene insertion originate?

In a recent study posted to the medRxiv* pre-print server, scientists at nference Labs investigated the origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) new variant of concern (VOC) Omicron's unique spike (S) gene insertion ins214EPE.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

In a recent phase III study published in the New England Journal of Medicine, researchers demonstrated that oral molnupiravir was effective in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) therapy among non-vaccinated, non-hospitalized adults at-risk for severe illness.

8 Jun 2022

A new coronavirus found in Swedish bank voles

Researchers report the discovery of the Gimso virus, a novel betacoronavirus in a bank vole from Grimso, Sweden

7 Jun 2022

Research explores effects of iron status on risk of sepsis and severe COVID-19

In a recent article posted to the medRxiv* preprint server, investigators demonstrated a link between high iron status and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- and sepsis-linked hospitalizations.

7 Jun 2022

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

In a recent study posted to the medRxiv pre-print server, researchers assessed the effectiveness of the Pfizer–BioNTech BNT162b2 coronavirus disease 2019 (COVID-19) vaccine in the seven million United Kingdom (UK) adults who were eligible to receive booster shots between 16 September and 16 December 2021.

7 Jun 2022

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

In a recent investigation published in the Annals of Internal Medicine journal, scientists demonstrated the positive impacts of molnupiravir among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and the healthcare sector apart from lowering disease-linked deaths and hospitalizations in at-risk cohorts.

7 Jun 2022

Gastrointestinal complications caused by SARS-CoV-2

scientists discuss the gastrointestinal complications associated with COVID-19.

7 Jun 2022

How do viruses evolve to infect new hosts?

Researchers discuss how protein thermostability prevents the misfolding of viral proteins from being heated.

7 Jun 2022

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

People with HIV have a higher rate of breakthrough COVID-19 infections after vaccination, compared to people without HIV, according to findings from a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

7 Jun 2022

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

A study co-led by the Universities of Oxford, Birmingham and Southampton and the UK Health Security Agency (UKHSA), published in Lancet Oncology today by the UK Coronavirus Cancer Evaluation Project, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalization and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

7 Jun 2022

SARS CoV 2 News and Research

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Study demonstrates mental health changes in the adult European population during the COVID-19 pandemic

The association between vitamin D status and infections, hospitalization, and mortality due to COVID-19

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

The origin of monkeypox outbreaks in non-endemic nations

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Pregnant women's social contacts and COVID vaccination coverage in 19 European countries

Newly identified coronavirus seems to be well established in Sweden's red-backed voles

Where did Omicron's unique spike gene insertion originate?

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

A new coronavirus found in Swedish bank voles

Research explores effects of iron status on risk of sepsis and severe COVID-19

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

Gastrointestinal complications caused by SARS-CoV-2

How do viruses evolve to infect new hosts?

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News